383 related articles for article (PubMed ID: 19457058)
21. Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects.
Xu N; Nilsson-Ehle P; Ahrén B
J Nutr Biochem; 2004 Oct; 15(10):579-82. PubMed ID: 15542348
[TBL] [Abstract][Full Text] [Related]
22. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
[TBL] [Abstract][Full Text] [Related]
23. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus.
Tan HC; Tai ES; Sviridov D; Nestel PJ; Ng C; Chan E; Teo Y; Wai DC
J Clin Lipidol; 2011; 5(6):467-73. PubMed ID: 22108150
[TBL] [Abstract][Full Text] [Related]
24. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans.
Kujiraoka T; Nanjee MN; Oka T; Ito M; Nagano M; Cooke CJ; Takahashi S; Olszewski WL; Wong JS; Stepanova IP; Hamilton RL; Egashira T; Hattori H; Miller NE
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1653-9. PubMed ID: 12893687
[TBL] [Abstract][Full Text] [Related]
25. An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA.
Cervin C; Axler O; Holmkvist J; Almgren P; Rantala E; Tuomi T; Groop L; Dahlbäck B; Karlsson E
J Intern Med; 2010 Mar; 267(3):316-21. PubMed ID: 19754856
[TBL] [Abstract][Full Text] [Related]
26. Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.
Watts GF; Ji J; Chan DC; Ooi EM; Johnson AG; Rye KA; Barrett PH
Clin Sci (Lond); 2006 Sep; 111(3):193-9. PubMed ID: 16700661
[TBL] [Abstract][Full Text] [Related]
27. A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia.
Al-Bahrani AI; Bakhiet CS; Bayoumi RA; Al-Yahyaee SA
Diabetes Res Clin Pract; 2005 Jul; 69(1):44-51. PubMed ID: 15904989
[TBL] [Abstract][Full Text] [Related]
28. Effect of weight reduction on the distribution of apolipoprotein A-I in high-density lipoprotein subfractions in obese non-insulin-dependent diabetic subjects.
Shige H; Nestel P; Sviridov D; Noakes M; Clifton P
Metabolism; 2000 Nov; 49(11):1453-9. PubMed ID: 11092511
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].
Muchacka-Bianga M; Deja G; Jarosz-Chobot P; Małecka-Tendera E; Kalina M; Grychtoł M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):25-30. PubMed ID: 16704858
[TBL] [Abstract][Full Text] [Related]
30. Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport.
Dullaart RP; van Tol A
Diabet Med; 2001 Jun; 18(6):509-13. PubMed ID: 11472472
[TBL] [Abstract][Full Text] [Related]
31. Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes.
Ooi EM; Ng TW; Chan DC; Watts GF
Diabetes Res Clin Pract; 2009 Sep; 85(3):310-6. PubMed ID: 19573945
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of apolipoprotein M as a biomarker of coronary artery disease.
Su W; Jiao G; Yang C; Ye Y
Clin Biochem; 2009 Mar; 42(4-5):365-70. PubMed ID: 19100249
[TBL] [Abstract][Full Text] [Related]
33. Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Tao Q; Zhang Y
Lipids Health Dis; 2016 Sep; 15(1):158. PubMed ID: 27633510
[TBL] [Abstract][Full Text] [Related]
34. Role of phospholipid transfer protein and prebeta-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects.
Dullaart RP; van Tol A
Scand J Clin Lab Invest; 2001 Feb; 61(1):69-74. PubMed ID: 11300613
[TBL] [Abstract][Full Text] [Related]
35. Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy.
Zhou H; Tan KC; Shiu SW; Wong Y
Nephrol Dial Transplant; 2008 Mar; 23(3):927-33. PubMed ID: 18065800
[TBL] [Abstract][Full Text] [Related]
36. Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: a FIELD substudy.
Maranghi M; Hiukka A; Badeau R; Sundvall J; Jauhiainen M; Taskinen MR
Atherosclerosis; 2011 Nov; 219(1):259-65. PubMed ID: 21696738
[TBL] [Abstract][Full Text] [Related]
37. Plasma concentrations of apolipoproteins A-I, B, and M in patients with critical limb ischemia.
Ahnström J; Gottsäter A; Lindblad B; Dahlbäck B
Clin Biochem; 2010 Apr; 43(6):599-603. PubMed ID: 20080084
[TBL] [Abstract][Full Text] [Related]
38. Plasma fatty acids and lipoproteins in type 2 diabetic patients.
Lapolla A; Sartore G; Della Rovere GR; Romanato G; Zambon S; Marin R; Manzato E; Fedele D
Diabetes Metab Res Rev; 2006; 22(3):226-31. PubMed ID: 16308886
[TBL] [Abstract][Full Text] [Related]
39. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
